GSK.L vs. SPY
Compare and contrast key facts about GlaxoSmithKline plc (GSK.L) and SPDR S&P 500 ETF (SPY).
SPY is a passively managed fund by State Street that tracks the performance of the S&P 500 Index. It was launched on Jan 22, 1993.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: GSK.L or SPY.
Key characteristics
| GSK.L | SPY | |
|---|---|---|
| YTD Return | 17.44% | 19.34% |
| 1Y Return | 23.87% | 26.92% |
| 3Y Return (Ann) | 8.27% | 9.30% |
| 5Y Return (Ann) | 3.76% | 15.86% |
| 10Y Return (Ann) | 6.28% | 12.90% |
| Sharpe Ratio | 1.19 | 2.17 |
| Daily Std Dev | 20.06% | 12.32% |
| Max Drawdown | -50.10% | -55.19% |
| Current Drawdown | -6.94% | -0.21% |
Correlation
The correlation between GSK.L and SPY is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
GSK.L vs. SPY - Performance Comparison
In the year-to-date period, GSK.L achieves a 17.44% return, which is significantly lower than SPY's 19.34% return. Over the past 10 years, GSK.L has underperformed SPY with an annualized return of 6.28%, while SPY has yielded a comparatively higher 12.90% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
GSK.L vs. SPY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for GlaxoSmithKline plc (GSK.L) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
GSK.L vs. SPY - Dividend Comparison
GSK.L's dividend yield for the trailing twelve months is around 3.62%, more than SPY's 1.21% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GSK.L GlaxoSmithKline plc | 3.62% | 3.84% | 4.66% | 4.93% | 5.90% | 4.45% | 5.31% | 5.99% | 4.88% | 5.77% | 5.76% | 5.62% |
SPY SPDR S&P 500 ETF | 1.21% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% | 1.87% | 1.81% |
Drawdowns
GSK.L vs. SPY - Drawdown Comparison
The maximum GSK.L drawdown since its inception was -50.10%, smaller than the maximum SPY drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for GSK.L and SPY. For additional features, visit the drawdowns tool.
Volatility
GSK.L vs. SPY - Volatility Comparison
GlaxoSmithKline plc (GSK.L) and SPDR S&P 500 ETF (SPY) have volatilities of 5.18% and 5.43%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.